The FDA’s Dr. Scott Gottlieb is set to tell the Senate Health, Education, Labor and Pensions Committee how the agency is protecting public health while spurring medical innovation.
Week Ahead: Senate committee to examine use of ‘cutting-edge’ science at FDA
